Table 1 Baseline characteristics of patients
Variables | Control (n = 96) | Intervention (n = 96) | p |
|---|---|---|---|
Male | 56 (58.3) | 67 (69.8) | 0.098 |
Age | 56.7 ± 13.4 | 59.4 ± 15.2 | 0.182 |
BMI | 22.6 ± 4.3 | 23.3 ± 4.5 | 0.323 |
CCI | 2.0 ± 1.6 | 2.5 ± 1.7 | 0.043 |
Diabetes | 19 (19.8) | 20 (20.8) | 0.858 |
Immunocompromised | 11 (11.5) | 4 (4.2) | 0.060 |
SOFA | 11.3 ± 3.7 | 10.3 ± 3.7 | 0.059 |
APACHE II | 20.2 ± 7.5 | 19.3 ± 6.6 | 0.377 |
Vasopressor | 82 (85.4) | 76 (79.2) | 0.257 |
Site of care | 0.978 | ||
Medical ICU | 17 (17.7) | 18 (18.8) | |
Surgical ICU | 46 (47.9) | 46 (47.9) | |
Mixed ICU | 33 (34.4) | 32 (33.3) | |
Mechanical ventilation | 90 (93.8) | 90 (93.8) | 1.000 |
Type of ECMO | 0.426 | ||
Cardiac | 36 (37.5) | 29 (30.2) | |
Respiratory | 47 (49.0) | 56 (58.3) | |
ECPR | 13 (13.5) | 11 (11.5) | |
ECMO mode | 0.147 | ||
VV | 48 (50.0) | 58 (60.4) | |
VA | 48 (50.0) | 38 (39.6) | |
Cannula configuration | 0.342 | ||
FV-JV | 46 (47.9) | 56 (58.3) | |
FV-FA | 48 (50.0) | 38 (39.6) | |
FV-FV | 2 (2.1) | 2 (2.1) | |
ECMO duration | 8.9 ± 9.2 | 9.2 ± 10.0 | 0.822 |
aLong-term ECMO support | 17 (17.7) | 16 (16.7) | 0.848 |
RRT use during ECMO | 51 (53.1) | 33 (34.4) | 0.009 |
RRT duration during ECMO | 9.7 ± 12.5 | 6.0 ± 5.4 | 0.108 |
Oxygenator function test | 9 (9.4) | 17 (17.7) | 0.092 |
Oxygenator change | 10 (10.4) | 14 (14.6) | 0.383 |